Pentoxifylline
Clinical data | |
---|---|
Pronunciation | /ˌpɛntɒkˈsɪfɪliːn, -ɪn/ |
Trade names | Trental, many other names worldwide[1] |
Other names | oxpentifylline (former AAN)[2] |
AHFS/Drugs.com | Monograph |
MedlinePlus | a685027 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
erythrocytes | |
Elimination half-life | 0.4–0.8 hours (1–1.6 hours for active metabolite)[3] |
Excretion | Urine (95%), faeces (<4%)[3] |
Identifiers | |
| |
JSmol) | |
| |
| |
(verify) |
Pentoxifylline, also known as oxpentifylline, is a xanthine derivative used as a drug to treat muscle pain in people with peripheral artery disease.[4] It is generic and sold under many brand names worldwide.[1]
Medical uses
Its primary use in medicine is to reduce pain, cramping, numbness, or weakness in the arms or legs which occurs due to
Pentoxifylline has been tested for use in
It has further been used to treat immunologic reactions to leprosy with some success.[12] Benefit in alcoholic hepatitis was shown, with some studies demonstrating a reduction in risk of hepatorenal syndrome.[citation needed] ForAn interesting off-label indication of pentoxifylline is the supportive treatment of distal
The combination of
Pentoxifylline may be used transdermally for cellulite treatment.
Adverse effects
Common side effects are belching, bloating, stomach discomfort or upset, nausea, vomiting,
Contraindications include intolerance to pentoxifylline or other xanthine derivatives, recent retinal or cerebral haemorrhage, and risk factors for haemorrhage.[3]
Mechanism
Like other methylated
Research
There is some evidence that pentoxifylline can lower the levels of some
Pentoxifylline, in combination with
In a Cochrane systematic review on the use of pentoxifylline for intermittent claudication in 2015, the following was concluded "The quality of included studies was generally low, and very large variability between studies was noted in reported findings including duration of trials, doses of pentoxifylline and distances participants could walk at the start of trials. Most included studies did not report on randomisation techniques or how treatment allocation was concealed, did not provide adequate information to permit judgement of selective reporting and did not report blinding of outcome assessors. Given all these factors, the role of pentoxifylline in intermittent claudication remains uncertain, although this medication was generally well tolerated by participants".[32][needs update]
See also
- Lisofylline, an active metabolite of pentoxifylline
- Propentofylline
- Cilostazol, a PDE-3 inhibitor with better evidence for intermittent claudication on the Cochrane review cited above.
References
- ^ a b Drugs.com drugs.com international listings for Pentoxifylline. Page accessed Feb 1, 206
- ^ a b c "PRODUCT INFORMATION TRENTAL® 400" (PDF). TGA eBusiness Services. sanofi-aventis australia pty limited. 25 March 2010. Retrieved 3 February 2014.
- ^ a b c d e "Trental, Pentoxil (pentoxifylline) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 3 February 2014.
- ^ PMID 33063850.
- ^ a b "PENTOXIFYLLINE tablet, extended release [Apotex Corp.]". DailyMed. Apotex Corp. February 2013. Retrieved 3 February 2014.
- ^ a b "Trental 400 - Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Sanofi. 10 October 2013. Retrieved 3 February 2014.
- ISBN 978-1-905813-66-7
- PMID 23235582.
- PMID 9154873.
- PMID 20560292.
- PMID 14555589.
- S2CID 46569413.
- PMID 33112447.
- PMID 34944074.
- PMID 35095501.
- S2CID 35396795.
- PMID 31741661.
- PMID 9274092.
- S2CID 236884968. Retrieved 2023-09-04.
- PMID 11692087.
- PMID 18568240.
- PMID 9927365.
- ^ PMID 15634873.
- S2CID 195697501.
- PMID 18220696.
- PMID 21477300.
- PMID 25392014.
- PMID 8790737.
- PMID 26579268.
- PMID 20638190.
- PMID 26975577.
- PMID 26417854.